新冠病毒疫苗公平分配的国际法律实践以及我国的因应措施  

International Legal Practice of Equitable Distribution of COVID-19 Vaccine and China's Response Measures

作　　者：李飞跃 Li Feiyue

机构地区：[1]中北大学出版中心

出　　处：《医学与法学》2021年第3期1-7,共7页Medicine and Jurisprudence

摘　　要：新冠病毒疫苗在国家间的公平分配不应以国家的能力为依据,且应优先满足特定群体;在新冠疫情下实现国家间疫苗公平分配的法律路径,有针对大流行性流感的防范框架、关于获取遗传资源与分享惠益的《名古屋议定书》和世卫组织主导下的全球新冠肺炎疫苗获取机制。建议进一步推广“人类卫生健康共同体”价值理念,做保护全球公共健康权的引领者;以新冠疫情为契机,进一步推动公平分配疫苗的法制化建设。The equitable distribution of COVID-19 vaccine among countries should not be based on national capacity and should give priority to specific groups.The legal frameworks achieving equitable distribution of vaccines among countries under the COVID-19 pandemic include the pandemic influenza preparedness framework,the Nagoya Protocol on Access to Genetic Resources and Benefit Sharing,and the WHO-led global COVID-19 vaccine access mechanism.It is suggested to further promote the value of the human health community and be a leader in protecting global public health right,and take the COVID-19 as an opportunity to further promote the legal construction of equitable distribution of vaccines.

关 键 词：新冠肺炎 疫苗 公平分配 国际法 健康权 

分 类 号：D99[政治法律—国际法学] D922.16[政治法律—法学]